QQQS
Invesco NASDAQ Future Gen 200 ETF
QQQS tracks an equal-weighted index of 200 NASDAQ-listed stocks selected based on the value of their patent portfolios. The portfolio excludes the largest 200 stocks listed on NASDAQ.
US
EQUITY
Rules-Based
MANAGEMENT STYLE
$ 11.5 M
ASSETS UNDER MGMT
20 bp
EXPENSES
Fund Basics
| Inception date | Oct 13, 2022 |
| Regulation | Open-Ended Fund |
| Fund Website | link... |
| Distributions | Quarterly |
| Currency | USD |
| Holdings Transparency | Full |
| Derivatives-based | No |
| Options available | No |
| Currency hedged | No |
| Fund of funds | No |
Top 10 Holdings
Complete list +
| UNIQURE N.V. | 1.5 % |
| CLEARPOINT NEURO, INC. | 1.2 % |
| NEKTAR THERAPEUTICS | 0.9 % |
| VUZIX CORPORATION | 0.8 % |
| OCUGEN INC | 0.8 % |
| ARROWHEAD PHARMACEUTICALS, INC. | 0.7 % |
| IONIS PHARMACEUTICALS, INC. | 0.7 % |
| CYTOMX THERAPEUTICS, INC. | 0.7 % |
| ARBE ROBOTICS LTD. | 0.7 % |
| AEROVIRONMENT INC | 0.7 % |
Constituent Breakdown
| Number of holdings | 189 |
| Herfindahl-Hirschman Index | 53 |
| Wgt avg mkt cap (mns) | $1,959 |
| Large cap (>$10bn) | 2.8% |
| Mid cap ($2-10bn) | 23.5% |
| Small cap (<$2bn) | 67.0% |
| Developed mkts. | 92.6% |
| Emerging mkts. | 1.4% |
Sector Breakdown
Country Exposure
 |
UNITED STATES | 82.9 % |
 |
ISRAEL | 2.6 % |
 |
CANADA | 2.3 % |
 |
NETHERLANDS | 1.5 % |
 |
CHINA | 1.4 % |
 |
BRITAIN | 0.9 % |
 |
HONG KONG | 0.6 % |
 |
IRELAND | 0.5 % |
 |
GERMANY | 0.5 % |
Historical Performance
Standardized Performance (as of 03/31/2026)
| YTD | 1 YR | 2 YR | 3 YR | 5 YR | 10 YR | 20 YR | Incep. | |
|---|---|---|---|---|---|---|---|---|
| Price Returns | -1.2% | 43.9% | 11.5% | 6.5% | -- | -- | -- | 8.6% |
| Dividend Yield | 0.2% | 5.3% | 2.5% | 1.8% | -- | -- | -- | 1.7% |
| Total Returns | -1.0% | 49.2% | 14.0% | 8.3% | -- | -- | -- | 10.3% | Ann. Volatility | 28.2% | 30.8% | 29.2% | 28.2% | -- | -- | -- | 28.4% |
Market Correlations
| versus... | Beta | R-squared |
| S&P 500 | 1.32 | 66% |
| MSCI EAFE | 1.24 | 51% |
| MSCI Emg Mkts | 1.07 | 49% |
Liquidity Measures
| Avg. volume (000) | 5 |
| ADV traded (mns) | $0 |
| Turnover | 1.7% |
| Avg. Bid/Ask (% of price) | 0.21% |
Technical Indicators
| 30d moving avg. (EMA) | $36.54 |
| Relative strength (RSI) | 62 |
| MACD/Signal | 1.22/0.90 |
| Bollinger Bands (Upper/Lower) | $40.89/$31.89 |
| Short interest (% of AUM) | 3.3% |
Distributions
Top Ten Comparable ETFs only shown here. For an extended list become an Individual or Professional subscriber. Start your FREE trial
Comparable ETFs Based on Overlap
| Ticker | Fund Name | Overlap vs. QQQS |
Expenses vs. QQQS |
ALTAR Score™ vs. QQQS |
|---|
Risk and Returns: QQQS vs. Comps (1 YR)
Notes: Top 10 overlapping ETFs. Funds with insufficient history not shown. Some funds may overlap. Hover over data point for ticker symbol.
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Results & Estimates (USD)
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|
| Sales per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Earnings per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Dividends per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Book value per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- |
Return on Equity
Net Margins
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Valuation Metrics
| Fwd Est | 2025 | 2026 | 2027 | |
| Price-to-sales | --x | --x | --x | --x |
| Price-to-earnings | --x | --x | --x | --x |
| Price-to-cash flow | --x | --x | --x | --x |
| Price-to-growth | --x | --x | --x | --x |
| Price-to-book value | --x | --x | --x | --x |
| Yield | --% | --% | --x | --% |
Based on closing prices from 4/30/2026
Peer Group Comparison Sample data. Subscribe for access.
Price-to-Earnings
Price-to-Sales
Price-to-Book Value
Price-to-Cash Flow
Price-to-Growth
Dividend Yield
Historical Valuation Trends Sample data. Subscribe for access.
SHOWING:
Price-to-Earnings
Price-to-Earnings
Notes: Based on adjusted historical results for current fund constituents. May differ from results achieved by past fund constituents. Max P/E of 100x.
Some content on this tab for Individual & Professional subscribers only. Start your FREE trial
ETF Research Center Rating
-3.6%
ALTAR SCORE™
1st
PERCENTILE
AVOID
ETFRC RATING
There are 1,199 funds in the US Equity category with an average
ALTAR Score™ of 5.5% and a standard deviation
of 2.1%. QQQS's ALTAR Score™ is approximately -4.4 standard
deviations above the category average. This places QQQS in the 1st percentile
among funds in the category.
Sell-Side Consensus
$47.54
PRICE TARGET
+24.4%
UPSIDE